The second meeting of the FDA's Transparency Task Force is to be held Tuesday from 9 a.m. to 3 p.m. EST at the National Transportation Safety Board Conference Center in Washington.
The FDA said the purpose of the meeting is to receive detailed comments on three specific issues related to transparency:
-- Early communication about emerging safety issues concerning FDA-regulated products.
-- Disclosure of information about product applications that are abandoned, i.e., no work is being done or will be undertaken to have the application approved, or withdrawn by the applicant before approval.
-- Communication of agency decisions about pending product applications.
The task force held its first daylong meeting in June.
Electronic comments may be submitted by Friday at http://www.regulations.gov.
The public meeting will be webcast live at http://www.capitolconnection.net/capcon/fda/110309/FDAlive.htm
Copyright 2009 by United Press International.
Post new comment